As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a study titled: Real-world effectiveness of guselkumab in patients with psoriasis: Health-related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial.
Independent expert commentary is provided by Clinical Associate Professor Kurt Gebauer, a dermatologist located in Fremantle.
Please login below to download this issue (PDF)